Fact CheckerSign in

NCT06191198RecruitingPhase 2

Communication Bridge 3 Study

Communication Bridge: Optimizing an Evidence-based Intervention for Individuals With Primary Progressive Aphasia

Source: ClinicalTrials.gov · Last updated 1 Jun 2026

Brief summary (registry, in English)

This study will use a randomized controlled trial design to evaluate the effect of two evidence-based treatments for adults with mild-moderate Primary Progressive Aphasia (PPA). The aim of the study is to help us better understand the effects of speech-language therapy on communication abilities in individuals with PPA.

Status (registry)
Recruiting
Phase (registry)
Phase 2
Study type
Interventional
Enrollment
200 (estimated)
First submitted
20 Dec 2023
Start date
23 Aug 2024
Primary completion date
15 Jul 2028
Lead sponsor
University of Chicago
NCT number
NCT06191198

What you commit to

  • Study type: Interventional · Phase 2
  • Planned participants: 200
  • From 23 Aug 2024 to the primary completion date, 15 Jul 2028
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Prior treatment

  • Participation is co-enrolled in an outside speech language therapy program during the study course.

Other illness

  • A dementia diagnosis other than Primary Progressive Aphasia
  • Communication partners will be excluded if they have a pre-existing communication impairment that would affect study participation (e.g., aphasia, dementia)
    • Medical records will be requested and reviewed to determine eligibility

Who the study is looking for

  • Meets diagnostic criteria for PPA based on neurologist and supporting medical assessments (extracted from medical records)
  • English as primary language used in daily communication activities (by self-report)
  • Adequate hearing (aided or unaided) for communicating with others in a crowded room (by self-report)
  • Adequate vision (aided or unaided) for reading a newspaper, or other functional materials (by self-report)
  • Able to pass technology screening and demonstrates sufficient knowledge for use of video conference and Communication Bridge™ web application use (with or without training)
  • Geriatric Depression Scale score ≤ 9
  • Mild-moderate PPA informed by a structured interview with a speech-language pathologist and a standardized testing battery.
  • 18+ years of age
  • English as primary language used in daily communication activities (by self-report)
  • Adequate hearing (aided or unaided) for communicating with others in a crowded room (by self-report)
  • Able to pass technology screening\* and demonstrates sufficient knowledge for use of video conference and Communication Bridge™ web application use (with or without training)

Age in the registry: 18 years to 100 years · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
University of Chicago - American School Building
Coordinator of this site? Confirm its status
ChicagoUnited StatesRecruiting

This page is information, not medical advice. Discuss any trial with your doctor.